Influence of Diet with Low Glycemic Index on Pro-inflammatory Interleukins in Patients with Metabolic Syndrome and Coronary Artery Disease

Alyavi, Baxrom; Uzokov, Jamol; Abdullaev, A.; Payziev, D D; Muxitdinova, O.

doi:10.1016/j.metabol.2020.154501

Cited by 6 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In studies [26], data were obtained on a significant positive effect of naftidrofuril: DBC and MTD compared with their values in the placebo group increased by 49 and 60%, respectively. Naftidrofuril showed better results compared to cilostazol and pentoxifylline in assessing DBC and IVD [27].…”

Section: Medical Treatmentmentioning

confidence: 99%

Contemporary view on chronic limb ischemia

Safaevich¹,

Kasimovich²

2022

GSC Biol. Pharm. Sci.

View full text Add to dashboard Cite

Chronic limb ischemia is a progressive and life threatening disease which in turn effects on quality of life. Up to date several studies have been conducted to timely identify and manage of the disease. Timely identification, diagnosis and treatment of this pathological condition will play crucial role to reduce burden in healthcare associated with this disorder. In this article latest data are shown on chronic limb ischemia, its pathophysiology, and treatment and prevention measurements together with general information on this disorder. Furthermore, latest clinical trials and studies are summarized in order in depth understand the exact mechanisms of the disease.

show abstract

Section: Medical Treatmentmentioning

confidence: 99%

Contemporary view on chronic limb ischemia

Safaevich¹,

Kasimovich²

2022

GSC Biol. Pharm. Sci.

View full text Add to dashboard Cite

show abstract

“…D-dimer levels greater than 1 µg/mL have been found to be associated with an increased risk of patient death during hospitalization. It is assumed that anticoagulation with low molecular weight heparin is associated with an increase in the survival of patients with a 6-fold increase in serum D-dimer, as well as in severe COVID-19 [19,21].…”

Section: Thromboembolic Complicationsmentioning

confidence: 99%

“…CHD is one of the main causes of death and disability in the world, and according to the definition of the American Heart Association and the American College of Cardiology, the coronary arteries of the heart cannot pump enough blood to meet the needs of the heart, in other words, the heart the balance between the demand for oxygen and its supply is disturbed. According to the definition of the European association of cardiologists, CHD is a pathological process caused by atherosclerosis, thrombosis or several other factors, in which the coronary arteries of the heart cannot supply blood according to the needs of the heart [5,18,19]. CHD is the most common type of cardiovascular disease, causing 360,900 deaths worldwide in 2019 alone [9].…”

Section: Introductionmentioning

confidence: 99%

Changes of the endothelial properties in patients with coronary artery disease after COVID-19

Ubaydullaev¹,

Alyavi²

2022

GSC Biol. Pharm. Sci.

View full text Add to dashboard Cite

COVID-19, like other respiratory viruses, has extra pulmonary manifestations. Like other organs cardiovascular system suffers from the virus. In particular, exposure to the virus leads to damage to the cardiovascular system (CVS), the pathophysiological mechanisms of which are not completely clear; a full understanding of the mechanisms of interaction between COVID-19 and CVS has not been formed. The article analyzes current ideas about COVID-19, considers possible links in pathogenesis, attempts to systematize the pathophysiological mechanisms of CVS damage and their complications, analyzes the relationship with cardiovascular comorbidity, and describes the features of pathomorphology and a hypothetical long-term prognosis. The presented information can contribute to understanding the two-way interaction of cardiovascular diseases and the effects of COVID-19 in order to develop effective preventive measures and make the right decision in choosing a therapeutic tactic for a patient within a systematic approach.

show abstract

“…• Elimination of warfarin, Angiotensin Converting Enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), aldosterone antagonists, thiazide diuretics and some antiarrhythmic drugs (amiodarone) • In class III and IV heart failure (NISA) after 20 weeks, exercise restriction and even bed rest are indicated • Common treatment options for heart failure and arrhythmias Frequent prenatal consultations, good rest, avoidance of excessive weight gain and stress, treatment of anemia [14]. An anesthesiologist familiar with cardiac disease in pregnant women should be present during labor and should ideally advise the patient prior to delivery [15]. Pain and anxiety are treated aggressively to minimize tachycardia during labor.…”

Section: Treatmentmentioning

confidence: 99%